Literature DB >> 12036667

Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision.

Jessica E Oliver1, Matthew G Hattenhauer, David Herman, David O Hodge, Robert Kennedy, Michael Fang-Yen, Douglas H Johnson.   

Abstract

PURPOSE: To compare patients becoming legally blind from glaucoma with those who did not go blind.
DESIGN: Retrospective, cohort, and case-control study.
METHODS: A retrospective community-based longitudinal study of residents of Olmsted County, Minnesota, who were newly diagnosed with open-angle glaucoma between 1965 and 1980 and followed through 1998. A case-control study was performed comparing patients progressing to legal blindness from glaucoma with aged-matched and visual field-matched patients not progressing to blindness.
RESULTS: Fifty-six of 290 patients progressed to legal blindness in at least one eye over the 34-year period of the study. Most who progressed to blindness had moderate to advanced visual field loss at the time of diagnosis of glaucoma. Those becoming legally blind had mean intraocular pressures (IOP) on therapy lower than or similar to patients who did not go blind, although the variability of IOP was higher in the blind group. Different susceptibilities to IOP were apparent, as some eyes with initially normal disks and visual fields became blind at an IOP of 20 mm, while others did not worsen. Changes in medical therapy after progression of visual field damage were less effective in lowering IOP in the group becoming blind than in the nonblind group.
CONCLUSIONS: Patients at greatest risk of blindness had visual field loss at the time of diagnosis of glaucoma. Different susceptibilities to IOP were apparent, with some patients becoming blind at pressures that others tolerated without significant progression. This suggests that continued monitoring of visual fields and reassessment of target IOP levels when field damage occurs are fundamental in the management of glaucoma.

Entities:  

Mesh:

Year:  2002        PMID: 12036667     DOI: 10.1016/s0002-9394(02)01403-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  45 in total

Review 1.  Imaging in glaucoma.

Authors:  Daniel M Stein; Gadi Wollstein; Joel S Schuman
Journal:  Ophthalmol Clin North Am       Date:  2004-03

2.  Risk of glaucoma among patients with benign essential blepharospasm.

Authors:  Michael S Lee; Andrew R Harrison; Daniel S Grossman; Frank A Sloan
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2010 Nov-Dec       Impact factor: 1.746

3.  Preventing blindness from glaucoma.

Authors:  David B Henson; Reshma Thampy
Journal:  BMJ       Date:  2005-07-16

Review 4.  The future of glaucoma clinics.

Authors:  A M S Morley; I Murdoch
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

5.  Imaging apoptosis in the eye.

Authors:  M F Cordeiro; C Migdal; P Bloom; F W Fitzke; S E Moss
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

6.  Association between Primary Open-Angle Glaucoma and Cognitive Impairment as Measured by the Montreal Cognitive Assessment.

Authors:  Makayla McCoskey; Victoria Addis; Kendall Goodyear; Prithvi S Sankar; Gui-Shuang Ying; Yinxi Yu; Rebecca Salowe; Qi N Cui; Eydie Miller-Ellis; Maureen Maguire; Joan M O Apos Brien
Journal:  Neurodegener Dis       Date:  2019-03-20       Impact factor: 2.977

7.  Preclinical imaging of iridocorneal angle and fundus using a modified integrated flexible handheld probe.

Authors:  Xun Jie Jeesmond Hong; Vengalathunadakal K Shinoj; Vadakke Matham Murukeshan; Mani Baskaran; Tin Aung
Journal:  J Med Imaging (Bellingham)       Date:  2017-04-10

Review 8.  Brain Machine Interfaces for Vision Restoration: The Current State of Cortical Visual Prosthetics.

Authors:  Soroush Niketeghad; Nader Pouratian
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

9.  Effect of the Aβ aggregation modulator MRZ-99030 on retinal damage in an animal model of glaucoma.

Authors:  T E Salt; S Nizari; M F Cordeiro; H Russ; W Danysz
Journal:  Neurotox Res       Date:  2014-08-09       Impact factor: 3.911

10.  Ten-year outcomes in newly diagnosed glaucoma patients: mortality and visual function.

Authors:  Tarun Sharma; John F Salmon
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.